Artificial Intelligence comes to informed consent to answer patients’ questions before surgery
Home News Artificial Intelligence comes to informed consent to answer patients’ questions before surgery

Artificial Intelligence comes to informed consent to answer patients’ questions before surgery

NOVEMBER 19, 2026 Members' News

Informed consent is a routine process in any hospital, but its management continues to generate costs, administrative workload and traceability issues when carried out on paper.

To address these challenges, ASHO has developed a new end-to-end informed consent management platform that digitizes the entire process and gives patients a more active role, allowing them to access the information in advance, resolve their questions before signing and arrive at surgery with a better understanding of the procedure.

“We want patients to arrive at surgery with their questions answered, while enabling hospitals to reduce administrative costs and avoid the problems caused by not being able to locate a consent form when it is needed. Ultimately, we want to use technology to humanize a process that, until now, has had a strong administrative component,” explains Gonzalo Hernández, ASHO’s Artificial Intelligence expert.

 

A fully digital process

The new solution allows all stages of the informed consent process to be managed through a single workflow, from the creation and delivery of the document to its signature, storage and subsequent access by the healthcare team.

Patients receive a personal link by email or SMS and can access the consent form from their mobile phone, tablet or computer in advance of the procedure, without having to visit the hospital beforehand.

The system eliminates the need to print, transport, store and scan hundreds of paper documents, as the consent form is created digitally and the signed PDF is automatically added to the patient’s medical record. In this way, the hospital reduces the administrative tasks associated with document management and avoids manual searches or reprinting when a consent form cannot be found.

In addition, the platform integrates with the hospital information system (HIS), allowing healthcare professionals to initiate the process from their usual working environment and subsequently check the status of the document without leaving it. Physicians also have access to a dashboard where they can see at a glance which consent forms have been signed, which are still pending and which have been rejected.

“Digitizing this process allows hospitals to save resources devoted to paper-based management and, above all, to have certainty at all times that the consent form is available when needed, avoiding searches, delays and unnecessary administrative tasks,” Hernández adds.

More information and greater patient autonomy One of the platform’s main differentiating features is the integration of an artificial intelligence assistant that supports patients as they read the informed consent form and allows them to ask questions about the procedure before signing it. Questions can be submitted in writing, by voice or through predefined prompts covering aspects such as the duration of the procedure, potential risks or pre-operative instructions.

The assistant generates its answers based on the hospital’s own official protocol, rather than on generic information from the Internet, meaning that patients receive information related specifically to the procedure they are authorizing. When a question falls outside the content available in the protocol, the system explicitly refers the patient to their doctor. In addition, the questions and answers are recorded and incorporated into the signed document as evidence of the understanding process.

“The main contribution of AI in this case is to provide patients with a space where they can ask questions calmly and as many times as they need, using the hospital’s own information as a basis and documenting that understanding process before signing,” adds ASHO’s AI expert.

ASHO’s new platform therefore brings together digital informed consent management, AI-powered question answering, electronic signatures and full process traceability in a single environment, connecting patients and healthcare professionals with the hospital’s information systems.

“The aim is for technology to help make informed consent a simpler and more transparent process for patients and, at the same time, a more efficient and traceable one for hospitals,” concludes Gonzalo Hernández.

November 20, 2026 Members' News
SMED Clinical Research joins the Barcelona & Madrid Health Hub
Joining Barcelona & Madrid Health Hub marks an important step for SMED Clinical Research as the company continues to strengthen its presence within the healthcare and life sciences ecosystem. It creates new opportunities to stay close to innovation, collaborate with leading organisations, and better understand the evolving needs of sponsors, clinical sites and the patients they serve.
Read more
November 19, 2026 Members' News
Partner Insights 2026: Technology, Innovation and Collaboration in Life Sciences
Ambit Iberia has launched Partner Insights 2026, the new edition of its annual magazine bringing together the perspectives of 13 technology partners on the trends, challenges and opportunities shaping the future of the Life Sciences industry.
Read more
November 19, 2026 Members' News
Artificial Intelligence comes to informed consent to answer patients’ questions before surgery
Informed consent is a routine process in any hospital, but its management continues to generate costs, administrative workload and traceability issues when carried out on paper. To address these challenges, ASHO has developed a new end-to-end informed consent management platform that digitizes the entire process and gives patients a more active role, allowing them to access the information in advance, resolve their questions before signing and arrive at surgery with a better understanding of the procedure.
Read more
November 18, 2026 Members' News
Corporate Nutrition for Every Type of Work. The Great Blind Spot in Workplace Wellness
Do we really take care of all the factors that influence team well-being? In recent years, companies have made progress in mental health, work-life balance, flexibility, and creating healthier work environments. However, there is one element that often remains outside the strategy or is treated in a merely informative way: nutrition during the workday.
Read more
November 16, 2026 Members' News
M2H brings exercise prescription into Primary Care: doctors and exercise specialists, finally on a single digital layer
The Barcelona-based healthtech startup, a new member of Barcelona & Madrid Health Hub, connects family doctors and Physical Exercise Specialists within the same clinical workflow, keeping full patient traceability.
Read more
November 13, 2026 Members' News
Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market
Most MedTech startups don't stall because the technology fails. They stall because funding and regulation were planned separately. Under MDR, compliance is not the last step before submission. It shapes your product and company decisions from day one. And investors know it: before a Series A or B, they expect a credible regulatory strategy, not just a promising prototype. That's why, QbD Group and Capital Cell teamed up, to bring both sides together in one free webinar live session.
Read more
November 13, 2026 Members' News
The Ultimate Guide for Choosing an Enterprise CMS
In strictly regulated industries like pharmaceutical and health insurance, delivering seamless, compliant digital experiences—from patient portals to provider resources—is critical. Magnolia is a leading composable Digital Experience Platform (DXP) trusted by healthcare and global enterprise giants like Sanofi and Generali. By centralizing websites, portals, and apps into one intuitive, open platform, Magnolia's CMS empowers IT teams to build freely and marketing teams to launch faster—all while protecting brand integrity and compliance.
Read more
November 12, 2026 Members' News
Health Tech Enterprise launches half-price UK market entry offer for Barcelona & Madrid Health Hub members
Health Tech Enterprise introduces an exclusive UK Market Entry Pathfinder offer for Barcelona & Madrid Health Hub members, helping MedTech companies assess their readiness for UK expansion and receive an evidence-based market entry recommendation within 21 days, with preferential member pricing available until 31 December 2026.
Read more
November 12, 2026 Members' News
Your Next Innovation May Already Exist
Connecting business challenges with scientific knowledge
Read more
November 04, 2026 Members' News
NeuronUP Academy, Barcelona Health Hub and Madrid Health Hub launch 60 scholarships in neuropsychology and neurorehabilitation
The joint initiative offers 60 scholarships for university programmes endorsed by EUNEIZ Universidad, with additional discounts guaranteed for Hub members.
Read more